In the exciting and rapidly expanding field of drug development, there is an emphasis on the clear delineation of psychiatric symptoms, syndromes and disorders, and disorders, and improved strategies for making diagnoses. Here the authors concentrate on the anxiolytics, a group of drugs which must be evaluated in carefully defined groups of patients using sensitive outcome measures. Efficacy is not always easy to establish and large clinical trials are needed to verify effectiveness of the drug, the degree of efficacy and ...
Read More
In the exciting and rapidly expanding field of drug development, there is an emphasis on the clear delineation of psychiatric symptoms, syndromes and disorders, and disorders, and improved strategies for making diagnoses. Here the authors concentrate on the anxiolytics, a group of drugs which must be evaluated in carefully defined groups of patients using sensitive outcome measures. Efficacy is not always easy to establish and large clinical trials are needed to verify effectiveness of the drug, the degree of efficacy and the risks of unwanted effects. Conducting these trials is not an easy matter and this timely, critical and comprehensive guide aims to provide awareness of the major issues surrounding development of anxiolytics and, in particular, details of the techniques needed to assess new and hopefully improved therapies. This book, written by authors well known for their extensive experience in the field of drug development, will be of interest to the academic community frequently involved in clinical trials of potential anxiolytic compounds, as well as to the pharmaceutical industry in the formulation of drug development programmes for new anxiolytics.
Read Less
Add this copy of Anxiolytic Compounds: Perspectives in Drug Development to cart. $49.00, new condition, Sold by Marsarbooks rated 3.0 out of 5 stars, ships from Cambridge, UNITED KINGDOM, published 1996 by John Wiley & Sons.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
New. No dust jacket as issued. Excellent as new condition. A brand new unread copy. Sewn binding. Cloth over boards. 163+ pages. Contains: illustrations, references, and a good index.
Add this copy of Anxiolytic Compounds: Perspectives in Drug Development to cart. $64.00, new condition, Sold by Marsarbooks rated 3.0 out of 5 stars, ships from Cambridge, UNITED KINGDOM, published by John Wiley.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Fine. No dust jacket, as issued. Excellent as new condition, perfect mint. A brand new copy. Unknown printing. (alk. paper) viii, 163 p. : ill.; 24 cm. ncludes bibliographical references and index.
Add this copy of Anxiolytic Compounds Perspectives in Drug Development to cart. $174.25, new condition, Sold by discount_scientific_books rated 5.0 out of 5 stars, ships from Sterling Heights, MI, UNITED STATES, published 1996 by Wiley.
